Fig. 3: Analysis of the correlation at time of first vaccination (T0), second vaccination (T1), and 3 weeks after (T2) in naïve and previously infected (P.I.) recipients. | Communications Medicine

Fig. 3: Analysis of the correlation at time of first vaccination (T0), second vaccination (T1), and 3 weeks after (T2) in naïve and previously infected (P.I.) recipients.

From: Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve

Fig. 3

a correlation between IgG-S(RBD) and neutralization (ID50) (sample sizes: T0 n = 48, T1 n = 50, T2 n = 49 for naïve, T0 and T1 n = 51, T2 n = 49 for P.I.); b correlation between IgG-S(RBD) and IgA (sample sizes: T0 n = 48, T1 n = 50, T2 n = 49 for naïve, T0 and T1 n = 51, T2 n = 49 for P.I.); c correlation between neutralization (ID50) and IgA-S (sample sizes: T0 n = 48, T1 n = 50, T2 n = 49 for naïve, T0 and T1 n = 51, T2 n = 49 for P.I.). The correlation was calculated using the two-sided Spearmen rank-correlation test.

Back to article page